ClinConnect ClinConnect Logo
Search / Trial NCT06294197

Examination of the Effects of Pelvic Floor Exercises on Vaginal and Sexual Health in Postmenopausal Women.

Launched by HATICE GULSAH KURNE · Feb 28, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Postmenopause Vagina Vaginal Dryness Sexual Function Dyspareunia Quality Of Life

ClinConnect Summary

This clinical trial is looking at how pelvic floor exercises can improve vaginal and sexual health in postmenopausal women, who often experience issues like vaginal dryness, burning, and pain during sex. These symptoms can affect a woman's sexual function and overall quality of life. In the study, participants will be divided into two groups: one group will perform pelvic floor exercises, while the other group will not receive any intervention. Both groups will have their vaginal health evaluated at the start and again after 12 weeks to see if the exercises made a difference.

To be eligible for this study, women need to be aged between 29 and 74, have not had a period for at least 12 months, and be sexually active. They also need to be able to read and understand information about the study. However, women with certain conditions, such as active vaginal infections or a history of certain cancers, will not be able to participate. If you join the study, you can expect to complete some questionnaires and tests to assess your vaginal health before and after the 12-week period. This research aims to provide valuable insights into how simple exercises can help with common postmenopausal symptoms.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Having applied to Istanbul Training and Research Hospital, Gynecology and Obstetrics Polyclinic
  • Being literate
  • Volunteering to participate in the study
  • Amenorrhea for 12 months
  • Being sexually active
  • BMI \< 35
  • Mini Mental Test Score threshold value for individuals over 65 years of age is 24
  • Exclusion Criteria:
  • Active vaginal infection
  • Having a history of active malignancy and receiving radiotherapy and/or chemotherapy accordingly
  • Having received Hormone Replacement Therapy within the last year,
  • Use of local estrogen
  • Coitus in the last two days
  • Pelvic organ prolapse stage 2 or higher
  • Having had mesh surgery
  • Presence of a disease/medication that causes vaginal dryness (e.g. Sjögren's syndrome, Lichen planus, Lichen Sclerosis / use of antidepressants or antihistamines).

About Hatice Gulsah Kurne

Hatice Gulsah Kurne is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical practices and compliance, Kurne leads initiatives that explore new therapeutic interventions across various medical fields. The organization emphasizes collaboration with healthcare professionals, research institutions, and regulatory bodies to ensure the highest standards of trial execution and data integrity. Through a patient-centered approach, Hatice Gulsah Kurne aims to contribute significantly to the advancement of medical science and the development of effective treatments.

Locations

Istanbul, Fatih, Turkey

Patients applied

0 patients applied

Trial Officials

Hatice Gülşah KÜRNE, MsC

Study Chair

Hacettepe University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported